Dr. Antonios O Aliprantis, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 850 Boylston St, Ste 130, Chestnut Hill, MA 02467 Phone: 617-732-9519 Fax: 617-732-9577 |
William Docken, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 850 Boylston St, Ste 130 Brigham And Women's Hosp Rheumatology Immunolog, Chestnut Hill, MA 02467 Phone: 617-732-9500 |
News Archive
A telestroke service increases the rate of effective tissue plasminogen activator therapy for patients with acute ischemic stroke treated at community hospitals, according to a report in the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Thermo Fisher Scientific Inc., the world leader in serving science, will highlight its innovative offering of products and services for clinical research and specialty diagnostics during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held in Anaheim, California, July 25 - 29, 2010.
CytoDyn Inc. ("CytoDyn") (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that CytoDyn Chief Medical Officer David Feigal, M.D., has submitted a revised protocol to the U.S. Food and Drug Administration relating to an upcoming Phase IIb clinical trial of PRO 140, CytoDyn's leading product under development as a treatment for Human Immunodeficiency Virus (HIV) infection.
Echo Therapeutics, Inc., a medical device company, today announced its financial results for the quarter ended September 30, 2014.
› Verified 2 days ago